BMRN vs DV · P/E 40, rev $2.85B vs P/E 31, rev $656.8M
Biomarin Pharmaceutical Inc (BMRN) versus DoubleVerify Holdings Inc (DV) — a side-by-side from cached financials, not a winner call.
Biomarin Pharmaceutical Inc (BMRN) is a biotechnology company listed on NASDAQ.
DoubleVerify Holdings Inc (DV) is a advertising agencies company listed on NYSE.
Latest reported BMRN revenue for 2024-12-31 was $2.85B. Net income was $426.9M. Revenue was up 18.0% from 2023-12-31 to 2024-12-31. BMRN currently screens at market cap $10.63B and trailing P/E 39.6.
Latest reported DV revenue for 2024-12-31 was $656.8M. Net income was $56.2M. Revenue was up 14.7% from 2023-12-31 to 2024-12-31. DV currently screens at market cap $1.57B and trailing P/E 30.9.
BMRN currently screens at market cap $10.63B and trailing P/E 39.6. DV currently screens at market cap $1.57B and trailing P/E 30.9.
Not investment advice. Open the BMRN and DV stock pages for the full models.
Not investment advice.